New rabies shot schedules tested in major 3,000-Person trial
NCT ID NCT07275645
Summary
This large Phase 3 trial aims to find the best schedule for a preventive rabies vaccine. It will enroll 3,000 people aged 10-60 to compare the immune response and safety of five different vaccination timing plans. The study will measure antibody levels and track any side effects to determine which schedule provides the strongest and longest-lasting protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gucheng county Center for Disease control and Prevention
Xiangyang, Hubei, China
-
Qichun County Center for Disease Control and Prevention
Huanggang, Hubei, China
-
Xiangzhou District Center for Disease Control and Prevention
Xiangyang, Hubei, China
-
Yunyang District Center for Disease Control and Prevention
Shiyan, Hubei, China
-
Zhushan county Center for Disease control and Prevention
Shiyan, Hubei, China
Conditions
Explore the condition pages connected to this study.